Telmisartan increases hepatic glucose production via protein kinase C ζ-dependent insulin receptor substrate-1 phosphorylation in HepG2 cells and mouse liver
Background Dysregulation of hepatic glucose production (HGP) contributes to the development of type 2 diabetes mellitus. Telmisartan, an angiotensin II type 1 receptor blocker (ARB), has various ancillary effects in addition to common blood pressure-lowering effects. The effects and mechanism of tel...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Yeungnam University College of Medicine
2019-01-01
|
Series: | Yeungnam University Journal of Medicine |
Subjects: | |
Online Access: | http://yujm.yu.ac.kr/upload/pdf/yujm-2019-00059.pdf |